185 related articles for article (PubMed ID: 3519548)
1. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
Navarrete C; Fernandez N; Alonso MC; Festenstein H
Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
[TBL] [Abstract][Full Text] [Related]
2. Gamma-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation.
Lecchi M; Lovisone E; Genetta C; Peruccio D; Resegotti L; Richiardi P
Leuk Res; 1989; 13(3):221-6. PubMed ID: 2496277
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
4. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
5. Class II alloantigen expression on leukemic cells.
Falkenrodt A; Urlacher A; Mayer S; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard S; Mitsuichi Y; Dormoy A
Nouv Rev Fr Hematol (1978); 1989; 31(3):209-16. PubMed ID: 2694093
[TBL] [Abstract][Full Text] [Related]
6. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
7. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells.
Fermand JP; Schmitt C; Brouet JC
Eur J Immunol; 1985 Dec; 15(12):1183-7. PubMed ID: 3878788
[TBL] [Abstract][Full Text] [Related]
8. Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expression.
Al-Katib A; Koziner B
Br J Haematol; 1984 Jul; 57(3):373-82. PubMed ID: 6378248
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of HLA-DR and HLA-DQ antigens on normal cells of the myelomonocytic lineage.
Alonso MC; Navarrete C; Solana R; Torres A; Pena J; Festenstein H
Tissue Antigens; 1985 Nov; 26(5):310-7. PubMed ID: 3867176
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
12. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
[TBL] [Abstract][Full Text] [Related]
13. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
14. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.
Ibisch C; Gallot G; Vivien R; Diez E; Jotereau F; Garand R; Vié H
Bone Marrow Transplant; 1999 Jun; 23(11):1153-9. PubMed ID: 10382955
[TBL] [Abstract][Full Text] [Related]
15. T cells specific for different antigens express different HLA-D region products.
Schendel DJ; Johnson JP
Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
[TBL] [Abstract][Full Text] [Related]
16. Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.
van Luijn MM; Chamuleau ME; Thompson JA; Ostrand-Rosenberg S; Westers TM; Souwer Y; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Haematologica; 2010 Mar; 95(3):485-93. PubMed ID: 19903675
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
18. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract][Full Text] [Related]
19. HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset.
Jaraquemada D; Navarrete C; Ollier W; Awad J; Okoye R; Festenstein H
Hum Immunol; 1986 Jul; 16(3):259-70. PubMed ID: 2424875
[TBL] [Abstract][Full Text] [Related]
20. Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation.
Amatruda TT; Bohman R; Ranyard J; Koeffler HP
Blood; 1987 Apr; 69(4):1225-36. PubMed ID: 3103718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]